Jun 08, 2017 - Looking for both good yields and solid business prospects is important. These stocks deliver the goods.
Jun 05, 2017 - Novartis AG (NVS) announced results from a phase II study, BRF113220, on the combination of Tafinlar and Mekinist at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO).
Jun 01, 2017 - The following slide deck was published by Novartis AG in conjunction with this event.
May 31, 2017 - Novartis AG (NVS) announced that the EMA has accepted its applications for biosimilar versions of AbbVie's (ABBV) Humira (adalimumab) and Johnson & Johnson's (JNJ) Remicade (infliximab) for review.
May 31, 2017 - Celgene's long thesis might be unraveling.
May 31, 2017 - Life with MS -- this world MS day, here's a look at 5 stocks including Biogen (BIIB) that are key players in the multiple sclerosis (MS) market.
May 30, 2017 - Looking for great dividend stocks of companies that make cholesterol drugs? Check out Amgen, AstraZeneca, Novartis, Pfizer, and Sanofi.
May 29, 2017 - Intercept Pharmaceuticals, Inc. (ICPT) announced that livver drug Ocaliva has obtained approval in Canada also.
May 29, 2017 - Kite Pharma, Inc. (KITE) announced that its biologics license application (BLA) for its experimental CAR-T therapy, axicabtagene ciloleucel has been accepted for priority review by the FDA.
May 26, 2017 - Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry.